These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 17253762)

  • 1. Designing a self-associated cationic polymer for enhanced compatibility, palatability, and gastric release of cefuroxime axetil.
    Menjoge AR; Kulkarni MG
    Biomacromolecules; 2007 Feb; 8(2):532-42. PubMed ID: 17253762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers.
    Lorenzo-Lamosa ML; Cuña M; Vila-Jato JL; Torres D; Alonso MJ
    J Microencapsul; 1997; 14(5):607-16. PubMed ID: 9292436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blends of reverse enteric polymer with Enteric and pH-independent polymers: mechanistic investigations for tailoring drug release.
    Menjoge AR; Kulkarni MG
    Biomacromolecules; 2007 Jan; 8(1):240-51. PubMed ID: 17206813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of cefuroxime axetil gastro-retentive floating drug delivery system via hot melt extrusion technology.
    Lalge R; Thipsay P; Shankar VK; Maurya A; Pimparade M; Bandari S; Zhang F; Murthy SN; Repka MA
    Int J Pharm; 2019 Jul; 566():520-531. PubMed ID: 31185262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation.
    Patel VF; Patel NM
    AAPS PharmSciTech; 2006 Feb; 7(1):E17. PubMed ID: 16584147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and characterization of cefuroxime axetil biphasic floating minitablets.
    Jammula S; Patra ChN; Swain S; Panigrahi KC; Nayak S; Dinda SC; Rao ME
    Drug Deliv; 2015 Jan; 22(1):125-35. PubMed ID: 24417642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids.
    Jun SW; Kim MS; Jo GH; Lee S; Woo JS; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Dec; 57(12):1529-37. PubMed ID: 16354397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A stability indicating assay method for cefuroxime axetil and its application to analysis of tablets exposed to accelerated stability test conditions.
    Ivana I; Ljiljana Z; Mira Z
    J Chromatogr A; 2006 Jun; 1119(1-2):209-15. PubMed ID: 16445930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime.
    Ruiz-Carretero P; Merino-Sanjuán M; Nácher A; Casabó VG
    Eur J Pharm Sci; 2004 Feb; 21(2-3):217-23. PubMed ID: 14757493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. Part 1: the influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres.
    Robson HJ; Craig DQ; Deutsch D
    Int J Pharm; 1999 Nov; 190(2):183-92. PubMed ID: 10547458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Biological Evaluation of High Molecular Weight Multifunctional Acid-Degradable Polymeric Drug Carriers with Structurally Different Ketals.
    Shenoi RA; Abbina S; Kizhakkedathu JN
    Biomacromolecules; 2016 Nov; 17(11):3683-3693. PubMed ID: 27750017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. III. The use of DSC and HSDSC as means of characterising the interaction of the microspheres with buffered media.
    Robson H; Craig DQ; Deutsch D
    Int J Pharm; 2000 May; 201(2):211-9. PubMed ID: 10878327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative Polymers for Controlled Release Applications.
    Zhong Z
    Biomacromolecules; 2017 Nov; 18(11):3652-3653. PubMed ID: 29129071
    [No Abstract]   [Full Text] [Related]  

  • 14. Design and optimization of artemether microparticles for bitter taste masking.
    Shah PP; Mashru RC; Rane YM; Badhan AC
    Acta Pharm; 2008 Dec; 58(4):379-92. PubMed ID: 19103573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in-vitro-in-vivo taste assessment of bitter drug: comparative electronic tongues study.
    Maniruzzaman M; Douroumis D
    J Pharm Pharmacol; 2015 Jan; 67(1):43-55. PubMed ID: 25182780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Smart' delivery systems for biomolecular therapeutics.
    Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
    Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue penetration following orally administered cefuroxime axetil.
    Wise R
    J Chemother; 1989 Jul; 1(4 Suppl):515-6. PubMed ID: 16312510
    [No Abstract]   [Full Text] [Related]  

  • 18. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
    Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
    ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. II. The effects of buffer composition on drug release.
    Robson H; Craig DQ; Deutsch D
    Int J Pharm; 2000 Feb; 195(1-2):137-45. PubMed ID: 10675691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel hydrogel membrane based on copoly(hydroxyethyl methacrylate/p-vinylbenzyl-poly(ethylene oxide)) for biomedical applications: properties and drug release characteristics.
    Arica MY; Bayramoglu G; Arica B; Yalçin E; Ito K; Yagci Y
    Macromol Biosci; 2005 Oct; 5(10):983-92. PubMed ID: 16208632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.